Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00034934
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
HRM | 7-METHOXY-1-METHYL-9H-BETA-CARBOLINE | A | 2Z5X | 0.7 | |
HRM | 7-METHOXY-1-METHYL-9H-BETA-CARBOLINE | A | 2Z5Y | 0.7 | |
3LG | (5-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETIC ACID | B | 2G26 | 0.7 | |
I48 | N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)- ETHOXY]-PHENYL}-BENZENESULFONAMIDE | H | 1UVT | 0.76 | |
PFJ | 6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN- 2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE | A | 2OVY | 0.71 | |
CQP | (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN- 2-YLMETHANESULFONYL)ISOQUINOLINE | A | 2C1B | 0.73 | |
L5G | 7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3- b]pyridazin-3-yl)methoxy]quinoline | A | 3CD8 | 0.71 | |
2PY | (2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}-3-[(7AS)-7AH-INDOL-3- YL]PROPAN-2-AMINE | E | 2OH0 | 0.72 | |
AB2 | [1-((1S,2R)-1-BENZYL-2-HYDROXY- 3-{ISOBUTYL[(4-METHOXYPHENYL)SULFONYL]AMINO}PROPYL)- 1H-1,2,3-TRIAZOL-4-YL]METHYL (1R,2R)- 2-HYDROXY-2,3-DIHYDRO-1H-INDEN- 1-YLCARBAMATE | A | 1ZP8 | 0.74 | |
AB2 | [1-((1S,2R)-1-BENZYL-2-HYDROXY- 3-{ISOBUTYL[(4-METHOXYPHENYL)SULFONYL]AMINO}PROPYL)- 1H-1,2,3-TRIAZOL-4-YL]METHYL (1R,2R)- 2-HYDROXY-2,3-DIHYDRO-1H-INDEN- 1-YLCARBAMATE | A,B | 2HC0 | 0.74 | |
4EA | (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)- 2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE | E | 2F7X | 0.73 | |
4LG | METHYL (6-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETATE | A,B | 2G27 | 0.71 | |
P13 | N-[2-(3-AMINOPROPOXY)-5-(1H-INDOL- 5-YL)BENZYL]-N-(2-PIPERAZIN-1-YLETHYL)AMINE | B | 1UTS | 0.71 | |
2EA | (1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN- 6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE | E | 2F7E | 0.72 | |
POS | 1-[[(4-PHENOXYPHENYL)SULFONYL]AMINO]- 3-[[N/N-(4-PYRIDINYLCARBONYL)-L- LEUCYL]AMINO]-2-PROPANOL | A | 1AU2 | 0.71 | |
I5S | ISOQUINOLINE-5-SULFONIC ACID (2- (2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE | A | 2JDO | 0.7 | |
I5S | ISOQUINOLINE-5-SULFONIC ACID (2- (2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE | A | 2JDT | 0.7 | |
I5S | ISOQUINOLINE-5-SULFONIC ACID (2- (2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE | A | 2C1A | 0.7 | |
SS5 | (2S)-1-[3-(CYCLOHEXYLMETHOXY)PHENYL]- 3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | A | 2UZV | 0.72 | |
SS3 | (2S)-1-{[5-(3-METHYL-1H-INDAZOL- 5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN- 2-AMINE | A | 2UZT | 0.73 | |
792 | N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}- 5-methyl-D-tryptophan | A,B,C,D | 3G42 | 0.71 | |
L20 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3- METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | A | 2JDS | 0.72 | |
L20 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3- METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | A | 2JDR | 0.72 | |
L20 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3- METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | A | 2JDV | 0.72 | |
L20 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3- METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | E | 2UZU | 0.72 | |
6EA | (1S)-1-(1H-INDOL-3-YLMETHYL)-2- (2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN- 5-YLOXY)-EHYLAMINE | E | 2F7Z | 0.76 |